Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis

Abstract

Objective To evaluate the application of proactive pro-drug therapy (TDM) at week six in users of infliximab therapy in ulcerative colitis patients and to analyze the need for further disease optimization.

Keywords

• ulcerative colitis
• colonoscopy
• infliximab
• remission induction
• therapeutic drug monitoring